Immune Cycle‐Based Strategies for Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Cycle‐Based Strategies for Cancer Immunotherapy

Published:2021-09-12 Issue:50 Volume:31 Page:2107540
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Li Yanhua¹,Liu Xiaohan¹,Zhang Xia¹,Pan Wei¹,Li Na¹,Tang Bo¹^ORCID

Affiliation:

1. College of Chemistry Chemical Engineering and Materials Science Key Laboratory of Molecular and Nano Probes Ministry of Education Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong Institute of Molecular and Nano Science Shandong Normal University Jinan 250014 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adfm.202107540

Reference244 articles.

1. Cancer Immunotherapy: A Treatment for the Masses

2. Cancer immunotherapy comes of age

3. Enhancing tumor T cell infiltration to enable cancer immunotherapy

4. CAR T cells: continuation in a revolution of immunotherapy

5. Cancer immunotherapy: the beginning of the end of cancer?

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09

2. Piezo-photodynamic therapy of Au@PEG-ZnO nanostructures enabled with a battery-free wireless cancer therapeutic dot;Nano Energy;2024-06

3. Activating Iterative Revolutions of the Cancer‐Immunity Cycle in Hypoxic Tumors with a Smart Nano‐Regulator;Advanced Materials;2024-05-20

4. Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy;Journal of Controlled Release;2024-01

5. Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade;Cancer Cell International;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3